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T cells that produce IL-17 (T helper 17 cells) are implicated in autoimmune pathogenesis. In this issue of
Immunity, Yang et al. (2008) report that the closely related orphan nuclear receptors RORa and RORgt
work together to regulate T helper (Th) 17 cell differentiation.Beginning in the early 1980s, T helper (Th)
cell differentiation was thought to be bi-
directional, resulting in the development
of either Th1 or Th2 effector cells. More
recently, however, a unique Th17 subset
has been described that produces inter-
leukin (IL)-17, but not IL-4 or interferon
(IFN)-g. Th17 cells differentiate in re-
sponse to specific cytokines present in
the lymphoid microenvironment (TGF-b,
IL-6, IL-21, IL-23) and have been impli-
cated in a variety of autoimmune disor-
ders in both mice and humans (Weaver
et al., 2006). Consistent with their defini-
tion as a bona fide T cell lineage, Th17
cells express at least one unique line-
age-specification factor, RORgt. A new
study from Yang et al. (2008) published
in this issue of Immunity identifies RORa
as also contributing to Th17 development,
thus providing exciting new insight into
the transcriptional regulation of Th17 dif-
ferentiation by orphan nuclear receptors.
Nuclear receptors are a large and di-
verse group of transcriptional regulatory
proteins that coordinate everything from
embryogenesis to tissue homeostasis in
vertebrates (Giguere, 1999). In addition
to steroid, thyroid, and retinoid receptors,
there are many so-called orphan nuclear
receptors for which no natural ligands
are known, but which have been assigned
to the nuclear receptor superfamily based
on conserved DNA- and ligand-binding
domains. Among nuclear receptors, reti-
noic acid receptors (RAR) and RAR-
related orphan nuclear receptors (ROR
or NR1F) have gained recent prominence
in T cell biology because of their regula-
tion of Th17 differentiation (Ivanov et al.,
2006; Mucida et al., 2007). Rora (RORa
or NR1F1), Rorb (RORb or NR1F2), andRorc (RORg or NR1F3) constitute the
ROR-NR1F gene family, and each gene
can yield multiple protein isoforms through
alternative promoter usage and variable
splicing (Giguere, 1999). RORa (NR1F1)
and RORb (NR1F2) are expressed in
the central nervous system and regulate
unique aspects of brain development and
function. Incontrast, a thymus-specific iso-
form of RORg, RORgt, whose expression
ishighly restricted toTcellswithin the intes-
tinal lamina propria, has been shown to
play a central role in Th17 differentiation:
ectopic overexpression ofRORgt in T cells
leads to a marked increase in IL-17-pro-
duction, whereas genetic deficiency
strongly impairs Th17 differentiation (Iva-
nov et al., 2006; Zhou et al., 2007).
In their study, Yang et al. (2008) found
that RORa is also expressed in Th17 cells,
but not in Th1 or Th2 cells. Like RORgt,
RORa was highly induced in T cells acti-
vated in vitro with a combination of TGF-b
and IL-6, and this induction was abro-
gated in STAT3-deficient T cells. Notably,
only one of the four known RORa iso-
forms, RORa4, was expressed in Th17
cells. The RORa isoforms (RORa1-a4)
vary only in their N-terminal transactiva-
tion (NTB) domains, which have been
shown to confer unique DNA-binding
specificities on RORa1 and RORa2
(Giguere et al., 1994; McBroom et al.,
1995). Thus among the many RORa and
RORg isoforms, RORa4 and RORgt may
have specialized roles in the regulation
of Th17-associated gene expression. It
will be important in future studies to inves-
tigate the mechanisms that control iso-
form-specific expression and individual
function of RORa and RORg proteins dur-
ing T cell differentiation.ImmYang et al. (2008) found that forced
expression of RORa4 (hereafter referred
to as RORa) induced IL-17 expression,
even when T cells were activated under
in vitro conditions that normally fail to
induce substantial IL-17 expression. Be-
cause these experiments did not rule
out the possibility that the primary effect
of RORa on Th17 gene expression is indi-
rect, for instance through the induction
of RORgt, the authors performed cotrans-
duction experiments. Consistent with the
hypothesis that RORa can directly regu-
late Th17 gene expression, they found
that coexpression of RORa and RORgt
caused synergistic increases in IL-17,
IL-17F, and IL-23R expression, as well
as histone acetylation of the CNS2
element located 50 of the Il17 promoter
within the Il17-Il17f locus. In addition,
the authors asked whether loss of RORa
function in T cells impairs Th17 differenti-
ation. To do this, they examined the phe-
notype of Staggerer mice (Gold et al.,
2007) (Rorasg), which lack a functional
RORa protein. Rorasg mice harbor a
6.5 kb genomic deletion in Rora, which
results in exon-skipping, frame-shifting,
and a premature stop codon, yielding
a nonfunctional truncated protein missing
much of its C-terminal ligand-binding do-
main (LBD). T cells isolated from Rorasg
mice displayed impaired Th17 differentia-
tion in vitro, and (in experiments with
bone marrow chimeras) caused less se-
vere experimental autoimmune encepha-
lomyelitis (EAE) disease than wild-type
T cells upon immunization and challenge
of Rag1/ recipients with MOG pep-
tide. These results demonstrate that the
Rorasg loss-of-function mutation pheno-
copies RORgt (Rorc) deficiency withunity 28, January 2008 ª2008 Elsevier Inc. 5
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PreviewsFigure 1. RORa and RORg May Act Redundantly or Cooperatively to Regulate Th17
Differentiation
Possible mechanisms, not mututally exclusive, whereby RORa and RORgt could regulate Th17-associ-
ated gene expression. Two genes bearing distinct retinoid response-like elements (ROREs), RORE-A
and RORE-B, are shown. RORa and RORgt could be functionally redundant, binding to the same ROR
response elements (ROREs) (top), they could bind to ROREs as heterodimers (middle), or they could
each individually recognize unique sets of ROREs (bottom). In reality, each RORa or RORgt target gene
is likely to contain several ROREs in its promoter and distal regulatory regions, and some or all of these
scenarios may apply.respect to Th17 differentiation (Ivanov
et al., 2006).
To extend their analyses, Yang et al.
(2008) crossed Rorasg mice to Rorc/
animals to generate progeny that were
functionally deficient in both ROR pro-
teins. They found that T cells lacking
both RORa and RORgt function were pro-
foundly impaired in their capacity to differ-
entiate into Th17 cells in vitro, even more
so than T cells lacking RORgt alone. The
entire program of Th17 differentiation was
compromised in these doubly deficient
T cells—production of IL-17F and expres-6 Immunity 28, January 2008 ª2008 Elseviersion of IL-21, IL-22, and IL-23 receptor
(IL-23R) were eliminated or greatly dimin-
ished. Furthermore, mice doubly deficient
in RORa and RORgt function were com-
pletely resistant to EAE, compared to
mice lacking only RORa or RORgt, which
developed more moderate and less fre-
quent disease than wild-type animals.
An important caveat of these experi-
ments is the use of Rorasg mice instead
of mice completely lacking any RORa
protein (Rora null mice). Although the trun-
cated RORa protein expressed in Rorasg
T cells is clearly a loss-of-function mutantInc.(Dussault et al., 1998; Gold et al., 2007), it
retains an intact DNA-binding domain and
thus may potentially compete with RORgt
or other nuclear receptors for binding
to ROR response elements (ROREs).
Indeed, the possibility that RORasg pos-
sesses some dominant-negative func-
tions is suggested by a previous study:
Rorasg and Rora null mice develop similar
gross developmental brain defects, but
RORb expression in the cerebellum was
lower in RORasg mice than in Rora null
mice, suggesting that RORasg perturbs
some aspects of gene regulation by nu-
clear receptors (Dussault et al., 1998).
The results also highlight the need to
understand in more detail how the unique
structural domains of RORa and RORgt
contribute to their function.
Although the relevant molecular mech-
anisms remain to be elucidated, these re-
sults confirm that both RORa and RORgt
play important roles in orchestrating
Th17 differentiation. But how? Do these
related proteins fill unique regulatory
niches in promoting Th17 cell develop-
ment, or are they functionally redundant?
Considering the highly similar DNA-bind-
ing domains of these two ROR family
members, a likely answer is that RORa
and RORgt regulate the expression of
Th17-associated genes through binding
to the same ROREs (Figure 1). This
hypothesis implies that the individual
expression amounts of RORa and RORgt
are limiting in T cells, leavingmanyROREs
unoccupied, and that expression of both
nuclear receptors is required to saturate
RORE binding sites and drive maximal
ROR-responsive gene expression. In sup-
port of this hypothesis, Yang et al. (2008)
found that either RORa or RORgt could
activate luciferase expression driven by
the CNS2 element containing only two
degenerate ROREs, but coexpression of
both proteins did not result in additional
activation. However, this artificial con-
struct does not recapitulate the native
regulatory context of the Il17 or Il17f
genes: it is likely that additional regulatory
elements that bind ROR proteins are
required. To establish functional redun-
dancy, it will be necessary to determine
whether RORa and RORgt bind the
same or distinct promoter elements and
promote distinct or overlapping patterns
of gene expression in T cells.
RORaandRORgtmayalsoenforceTh17
differentiation in a nonredundant manner
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and IL-22 expression were unaffected by
the absence of RORgt (Zhou et al., 2007)
and RORa, respectively, but T cells from
RORa and RORgt double-deficient mice
showed a clear deficit in expression of
both these cytokines. What might be the
molecular basis for these phenotypic dis-
crepancies? Possible scenarios are that
the two nuclear receptors display different
binding specificities, preferring distinct
subsets of ROREs, or that they bind to
DNA as heterodimers. Like all nuclear re-
ceptors, ROR proteins have been shown
to bind cognate DNA elements as mono-
mers or dimers: as monomers to ROREs
containing a single consensus half site
(PuGGTCA) immediately preceded by a
short A/T-rich region, and as dimers to
tandem half sites oriented as palin-
dromes, inverted palindromes, or direct
repeats (Giguere, 1999). Indeed, RORa:
RORgt heterodimers could posses dis-
tinct functional activity compared to
monomers or homodimers because of
their unique N-terminal trans-activation
domains (NTDs). These same isoform-
specific NTDs could confer the ability to
recognize distinct sets of ROREs on
RORa and RORgt (Giguere et al., 1994;
McBroom et al., 1995).
These considerations urge ameticulous
dissection of the in situ DNA-binding
specificities of RORa and RORgt. In this
context, Yang et al. (2008) performed a
series of ChIP and EMSA experiments toinvestigate RORa and RORgt binding to
putative ROREs present within the CNS2
region of the Il17-Il17f locus. However,
the low resolution of ChIP experiments
and the fact that many nuclear receptors
expressed in T cells can potentially bind
to retinoid response-like elements means
that it will be difficult to identify precisely
which DNA elements in target genes actu-
ally represent RORa and RORgt DNA-
binding sites during T cell differentiation.
Here as elsewhere, the gap between the
test tube and the cell is huge: in vitro ex-
periments with recombinant proteins pro-
vide precise quantitative data on DNA
binding specificities, but in cells, binding
occurs in the context of post-translational
modifications and the correct comple-
ment of associated nuclear partners,
which, except in rare cases, are not
known. New andmore sensitive technolo-
gies are needed to identify with base-pair
precision which regions of DNA are occu-
pied by which transcription factors in the
nucleosomal context.
Nuclear receptors provide a direct,
dynamic, and precise mechanism for
cellular responses to hormones and me-
tabolites. Natural ligands and synthetic
compounds that modulate the function
of nuclear receptors have demonstrated
tremendous therapeutic potential for a va-
riety of clinical disorders (Dhingra, 2001).
The identification of RORa and RORgt
as key regulators of the Th17 lineage sug-
gests that targeting these receptors couldImmbe a viable strategy for treating autoim-
mune pathologies linked to Th17 effector
function.
REFERENCES
Dhingra, K. (2001). Cancer Invest. 19, 649–659.
Dussault, I., Fawcett, D., Matthyssen, A., Bader,
J.A., and Giguere, V. (1998). Mech. Dev. 70,
147–153.
Giguere, V. (1999). Endocr. Rev. 20, 689–725.
Giguere, V., Tini, M., Flock, G., Ong, E., Evans,
R.M., and Otulakowski, G. (1994). Genes Dev. 8,
538–553.
Gold, D.A., Gent, P.M., and Hamilton, B.A. (2007).
Brain Res. 1140, 19–25.
Ivanov, I.I.,McKenzie,B.S.,Zhou,L., Tadokoro,C.E.,
Lepelley, A., Lafaille, J.J., Cua, D.J., and Littman,
D.R. (2006). Cell 126, 1121–1133.
McBroom, L.D., Flock, G., and Giguere, V. (1995).
Mol. Cell. Biol. 15, 796–808.
Mucida, D., Park, Y., Kim, G., Turovskaya, O.,
Scott, I., Kronenberg, M., and Cheroutre, H.
(2007). Science 317, 256–260.
Weaver, C.T., Harrington, L.E., Mangan, P.R.,
Gavrieli, M., and Murphy, K.M. (2006). Immunity
24, 677–688.
Yang, X.O., Pappu, B.P., Nurieva, R., Akimzhanov,
A., Kang, H.S., Chung, Y., Ma, L., Shah, B.,
Panopoulos, A.D., Schluns, K.S., et al. (2008).
Immunity 28, this issue, 29–39.
Zhou, L., Ivanov, I.I., Spolski, R., Min, R.,
Shenderov, K., Egawa, T., Levy, D.E., Leonard,
W.J., and Littman, D.R. (2007). Nat. Immunol. 8,
967–974.unity 28, January 2008 ª2008 Elsevier Inc. 7
